Epigenetic modification of SELENBP1 through promoter methylation in cancer has been demonstrated in many studies: DNA methylation at CpG islands in promoter regions is regulated by the DNA methyltransferase (DNMT) enzyme. Here, SELENBP1 is linked to cancer.